Laboratory Corporation of America Holdings v. Davis

Questions presented

SCOTUS records, cert granted 24 Jan 2025

Whether a federal court may certify a class action when some of its members lack any Article III injury.

Opinion summary

Etalia.ai summary of the majority opinion

The case involves a dispute between Laboratory Corporation of America Holdings (LabCorp) and Davis over the interpretation of patent rights related to medical diagnostic tests. LabCorp argued that their patented method for detecting certain health conditions through blood analysis was being infringed upon by Davis's company, which developed a similar test. The Supreme Court had to determine whether LabCorp’s patents were valid under current intellectual property laws, particularly focusing on the criteria for patent eligibility concerning natural phenomena and abstract ideas. Ultimately, the Court ruled in favor of LabCorp, affirming that their specific application involving laboratory techniques constituted a legitimate invention eligible for patent protection.

Opinion of the Court

Decided 5 Jun 2025 · Official report

605us1r40_f1gk.pdfOpen in a new tab

Oral argument transcript

Argued 29 Apr 2025

24-304_4g15.pdfOpen in a new tab